NextCure

Contributing Author

Recent Articles by NextCure

Nov-20	NextCure to Present at the Piper Sandler 37th Annual Healthcare Conference NXTC GlobeNewswire
Nov-17	NextCure Announces Closing of $21.5 Million PIPE Financing in Advance of First Half 2026 Phase 1 POC Data Readouts NXTC GlobeNewswire
Nov-12	NextCure Announces $21.5 Million Private Placement of Common Stock Priced at the Market Under Nasdaq Rules NXTC GlobeNewswire
Nov-05	NextCure Provides Business Update and Reports Third Quarter 2025 Financial Results NXTC GlobeNewswire
Oct-16	NextCure and Simcere Zaiming Announce Expansion of Ongoing Phase 1 Trial of SIM0505 (CDH6 ADC) into the United States NXTC GlobeNewswire
Sep-04	NextCure to Present at the H.C. Wainwright 27th Annual Global Investment Conference NXTC GlobeNewswire
Aug-07	NextCure Provides Business Update and Reports Second Quarter 2025 Financial Results NXTC GlobeNewswire
Jul-24	Preclinical Data Demonstrate Anti-Siglec-15 Treatment Improves Bone Microarchitecture and Reduces Fracture Incidence in Mice with Moderate-to-Severe Osteogenesis Imperfecta NXTC GlobeNewswire
Jun-16	NextCure and Simcere Zaiming Announce Strategic Partnership for a Novel Antibody-Drug Conjugate Targeting CDH6 NXTC GlobeNewswire
May-29	NextCure and LigaChemBio to Present Trial in Progress Poster for LNCB74, a B7-H4 Targeted Antibody-Drug Conjugate, as Monotherapy in Participants with Advanced Solid Tumors at ASCO 2025 NXTC GlobeNewswire
May-01	NextCure Provides Business Update and Reports First Quarter 2025 Financial Results NXTC GlobeNewswire